Contact us contattaci
logo
EN
IT ES DE FR
logo
The Group
About Us Manufacturing Sites Identity Sustainability Technology and Patents
Manufacturing sites
Mereto di Tomba Gallarate San Pietro Viminario Biofarma Group France US Pharma Lab
Product Lines
Food supplements Medical devices Cosmetics Probiotics Clinical studies
Services
Research & Development Quality Control Laboratory Regulatory Advice Production Packaging Logistics Certification, Licenses and Policies
Contacts
Careers
Agenda
Press Room
Investors
Reserved area

Biofarma Group announces the acquisition of US Pharma Lab

Data: 26_07_2023
Category: Press Review
Home / Press Room / Biofarma Group announces the acquisition of US Pharma Lab

Biofarma Group announces the creation of the first global CDMO fully focused on Nutraceuticals through the acquisition of US Pharma Lab, a premium and highly innovative US-based player

> Download pdf
expand
logo
The Group About Us Manufacturing Sites Identity Sustainability Technology and Patents
Manufacturing sites Mereto di Tomba Gallarate San Pietro Viminario Biofarma Group France US Pharma Lab
Product Lines Food supplements Medical devices Cosmetics Probiotics Clinical studies
Services Research & Development Quality Control Laboratory Regulatory Advice Production Packaging Logistics Certification, Licenses and Policies
Contact us Contacts Terms and conditions Privacy policy Cookie policy Legal Notices Press Room Investors
© Biofarma Srl C.F. and P.IVA 02895910301
T. +39 0432 868711 F. +39 0432 868018
Via Castelliere, 2
33036 Mereto di Tomba (UD) Italy
Number REA UD - 296214
Date of entry in the
Business Register of UDINE: 01/07/2017
Registration number: 02895910301
Share capital euro 3.000.000
Posta.certificata@pec.biofarma.it
Linkedin Linkedin